IL6R and inflammatory bowel disease: Current medication used in IBD consists of anti-inflammatory drugs (mesalazine, corticosteroids), immunosuppressives (Azathioprine, 6-mercaptopurine, Methotrexate), and biologics (Infliximab and Adalimumab—antitumor necrosis factor antibodies, Vedolizumab—monoclonal antibody with gut selectivity that inhibits α4β7 integrin, Ustekinumab—IL-12 and IL-23 antagonist, Tocilizumab—anti-IL-6R antibody, Tofacitinib—Janus kinase inhibitor) [10].